Refine by
Emergency Patient Articles & Analysis
14 news found
At best, most of us tolerate needles. Whether a vaccine, an IV drip, or a blood draw, we can talk ourselves through it with the knowledge that it is for the greater good and will only cause temporary discomfort. On the other side of the spectrum, there are people with such an intense fear of needles that they are considered to have a phobia, trypanophobia to be precise. Many articles have been ...
Baliga BIOS-03: Real world clinical outcomes of patients with diffuse midline glioma in a longitudinal outcomes registry Timothy J. ...
ByxCures
Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4% patient compliance to date with novel OMIT therapeutic modality Safely started patients on dose 4, potentially reducing the time to reach maintenance by several weeks NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., ...
With BrainScope, many patients can be spared unnecessary radiation from head CT while also benefiting from significantly faster wait times. ...
“More than four million patients seek care each year at hospital emergency departments for mild traumatic brain injuries. ...
“We are highly focused on integrating state-of-the-art medical technologies into our hospital to provide our patients with the best possible outcomes,” said Professor Dr. Ichiro Takemasa, Chairman of Surgical Oncology and Science. ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, ...
Anuncia Inc., an emerging leader in Cerebral Spinal Fluid (CSF) management, received U.S. ...
The Bethesda, Maryland based company is helping hospital Emergency Departments (EDs) objectively triage the almost five million patients that present each year with suspected mild traumatic brain injuries. ...
Thermo Fisher Scientific will host a symposium featuring customer presentations that highlight the latest efforts in tumor mutation burden (TMB) standardization by its European consortium, and clinical research data focused on the application of this emerging biomarker to help guide selection of immunotherapies. The talks will take place Sept. 10 during the 30th European Congress ...
Awareness of hygiene requirements for protection of both the patient and the healthcare provider is improving in these regions. Latin America is maintaining a lead in this race, followed by China and India. Marketstrat predicts the highest growth in emerging markets will be in the latex and vinyl glove segments. In the relatively saturated markets of the US, ...
The PRCCSD applied circumferentially about the patient exerts a compressive force to reduce and stabilize disruptions of the pelvic ring. ...
Specific technology makes it easier to comply with new norms for hygiene, safety and (patient) welfare. The German care & cure market is an important growth market for ...
Learn about five initiatives of Alberta Health Services: clinical information systems interactive costing of care records and personal health records emergency department in-patient real time measurement netCare applications communicable disease and outbreak management To view the full agenda for this event, incuding all speakers and session ...